Translational imaging of apoptosis

Area of Science:

• Biomedical imaging
• Molecular biology
• Disease diagnostics

Background:

• Deregulated apoptosis (programmed cell death) is implicated in diseases like myocardial infarction, ischemia, neurodegenerative disorders, and cancer.
• Quantitative in vivo apoptosis detection is vital for clinical diagnosis, patient management, and therapeutic development.

Purpose of the Study:

• To review the development of novel apoptosis-detecting probes.
• To identify probes capable of bridging different evaluation stages (in vitro, animal models, clinical trials).
• To enhance the accuracy and reproducibility of translational apoptosis imaging data.

Main Methods:

• Review of current literature on apoptosis imaging probes.
• Analysis of probe suitability for various stages of therapeutic evaluation.
• Focus on probes enabling consistent, quantitative apoptosis detection.

Main Results:

• Current apoptosis imaging necessitates switching probe types during development, impacting data quality.
• New probes are being developed with the potential for cross-stage applicability.
• These novel probes aim to provide accurate, translational apoptosis imaging.

Conclusions:

• Developing a single, versatile probe for apoptosis imaging across all research and clinical stages is a key goal.
• Such probes would improve the quality and reproducibility of data in disease diagnosis and drug development.
• Advancements in apoptosis imaging probes promise more reliable patient management and therapeutic evaluation.